Mechanisms of Autoimmunity – MAI
Starts with January 2025 council round submission dates
The Mechanisms of Autoimmunity (MAI) study section reviews applications that address basic and clinically related immunological mechanisms of failed self-tolerance in the context of autoimmunity. Studies can be conducted in both human and/or animal models as well as in vitro systems, using molecular, cellular, genomic and proteomic approaches.
Review Dates
Topics
- Immunological processes related to organ specific and systemic autoimmune diseases, including autoimmune diseases of the nervous system, skin, endocrine, hematologic, lungs and rheumatic diseases. Diseases of interest include systemic lupus erythematosus, Sjögren’s syndrome, multiple sclerosis, type I diabetes, autoimmune arthritis, idiopathic inflammatory myopathies, psoriasis, sarcoidosis, and primary immunodeficiency related hypersensitivity.
- Environmental and genetic factors involved in immune pathway triggers and autoimmunity.
- Maintenance and breakage of central tolerance, peripheral tolerance and immune homeostasis leading to the development of autoimmunity.
- Strategies for reestablishing a normal immune balance for treatment of autoimmune diseases.
Shared Interests and Overlaps
There are shared interests with Innate Immunity A (IIDA (81)), Innate Immunity B (IIB), and Adaptive Immunity (AI). Fundamental processes and functions that pertain to immune system regulation and response may be reviewed in IIDA (81), IIB, or AI. The immunopathologic consequences or failures of immunoregulation that lead to autoimmunity may be reviewed in MAI.
There are shared interests with Lung Immunology and Infection (LII). Applications focused on the immunological response to pathogen invasion in the lung may be reviewed in LII, whereas lung complications associated with an autoimmune or rheumatic disease may be reviewed in MAI.
There are shared interests with Skin and Connective Tissue Science (SCTS) in skin and connective tissue-associated immune responses. Applications with focus on the pathophysiology of the skin, skin appendages and connective tissue in the context of autoimmune disease may be reviewed in SCTS. Applications studying immune cells, immune mechanisms and/or responses, either innate or adaptive, in the context of skin-associated autoimmunity may be reviewed in MAI.
There are shared interests with Immunobiology of Transplantation and Alloimmunity (ITA) regarding diseases that affect induction, maintenance and breaking of immune tolerance. Applications proposing to study tolerance mechanisms and autoimmunity in relation to transplantation may be reviewed by ITA. Applications focused on immune tolerance to understand the pathogenesis and prevention of autoimmunity may be reviewed by MAI.
There are shared interests with Clinical Neuroimmunology and Brain Tumors (CNBT), Behavioral Neuroendocrinology, Neuroimmunology, Rhythms and Sleep (BNRS), and Cellular and Molecular Biology of Glia (CMBG). Applications examining neural tissue and processes associated with neural diseases may be reviewed in CNBT, BNRS or CMBG, whereas applications that focus on autoimmune mechanisms of neurologic damage may be reviewed in MAI.
There are shared interests with Basic Mechanisms of Diabetes and Metabolism (BMDM) regarding immune modulation of adipocytes, islet cell function, and diabetes. Applications focused on immune cell modulation of pancreatic islet cell function, molecular alterations of islet cells contributing to diabetes etiopathogenesis and pathobiology (e.g., type 1 diabetes) may be reviewed by BMDM, whereas those focused on understanding immune cell function and regulation related to type 1 diabetes onset may be reviewed in MAI.
There are shared interests with Translational Investigations of Pulmonary and Immunological Diseases (RCCS (81)). Translational research that uses study cohorts and clinical trial platforms to examine strategies to prevent and/or ameliorate autoimmune disease may be reviewed in RCCS (81), whereas applications that address immunological mechanisms of failed self-tolerance in the context of autoimmunity that use human and/or animal models as well as in vitro systems, molecular, cellular, genomic and proteomic approaches may be reviewed in MAI.